Angela M Valverde, DiBaN participant from CSIC, was interviewed by the Spanish Diabetes Federation on the preclinical research of a novel dual GLP-1/glucagon receptor agonist in the mimicking metabolic rewiring and inter-organ cross-talk of bariatric surgery